Monday's IBD 50 Stocks To Watch pick is Exelixis, which is just below a recent buy point in today's stock market rally. That makes Exelixis stock one of the best names to buy and watch right now.

The authors noted that while an association between cigarette smoking and TED has been well established, an association ...

Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data ...

The treatment was approved by China’s National Medical Products Administration (NMPA) and is China's first, and the world’s ...

China’s National Medical Products Administration (NMPA) approved the country’s first injectable teprotumumab biosimilar from Innovent Biologics Inc. under the brand name of Sycume (teprotumumab N-01) ...

Given these promising results and a strong scientific rationale, combined with LX-101’s novel mechanism of action and prior positive clinical experience in oncology, Lirum is planning new clinical ...

An announcement from Innovent Biologics ( ($HK:1801) ) is now available. Innovent Biologics has announced the approval of SYCUME®, China’s first ...

At other times, the swelling (also known as periorbital edema) may be a sign of a potentially serious medical condition like an eye infection, thyroid disease, or diabetes. Certain clues can point you ...

Thyroid diseases are characterized by hyperfunction (hyperthyroidism), hypofunction (hypothyoidism) or inflammation (thyroiditis) of the thyroid gland or the presence of thyroid nodules, which can ...

Batoclimab receives Orphan Drug Designation in Japan, advancing treatment for active Thyroid Eye Disease (TED). Batoclimab, subcutaneous formulation, offers the potential for at-home administration, ...